This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Character.AI seeks quick US appeals court decision on AI speech protections

By Amy Miller ( June 19, 2025, 22:40 GMT | Insight) -- Character.AI wants a US appeals court to decide quickly if conversations generated by artificial intelligence-powered chatbots are protected by the First Amendment after US District Judge Ann Conway allowed a wrongful death lawsuit against the company to move forward. Character.AI is seeking permission to immediately appeal Conway's decision, arguing her ruling could chill AI innovation and free speech. “The parties, the public, the nascent AI industry, and the millions of American users of generative AI services would benefit from appellate guidance now, not later," the company said.Character.AI wants a US appeals court to decide quickly on whether conversations generated by artificial intelligence-powered chatbots are protected by the First Amendment after a federal judge allowed a wrongful death lawsuit against the company to move toward trial....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections